Diane Gulyas - Ingevity Corp Independent Director

NGVT Stock  USD 48.56  0.15  0.31%   

Director

Ms. Diane H. Gulyas is Independent Director of the Company. Prior to her retirement in 2014, Ms. Gulyas worked at E.I. du Pont de Nemours and Company for over 35 years, serving as President of the Performance Polymers business from 2009 until her retirement in 2014. Previously, Ms. Gulyas held various positions including as the Company Global Chief Marketing and Sales Officer, Group Vice President of the company Electronic and Communication Technologies platform, and Vice President and General Manager of the Company Advanced Fiber business. Since 2015, Ms. Gulyas has served on the of the Board of W.R. Grace Co., a specialty chemicals company, where she is the Chair of the Compensation Committee, and on the board of Expeditors International of Washington, Inc., a global logistics services company. Ms. Gulyas previously served on the boards of Mallinckrodt Pharmaceuticals and Navistar International Corporation since 2019.
Age 64
Tenure 5 years
Address 4920 O'Hear Avenue, North Charleston, SC, United States, 29405
Phone843 740 2300
Webhttps://www.ingevity.com
Gulyas holds a BS degree in chemical engineering from the University of Notre Dame and completed the Advanced Management Program at the Wharton School of the University of Pennsylvania. She is also a member of the Board of Directors of the Ladies Professional Golfing Association.

Ingevity Corp Management Efficiency

The company has return on total asset (ROA) of 0.0585 % which means that it generated a profit of $0.0585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2081) %, meaning that it created substantial loss on money invested by shareholders. Ingevity Corp's management efficiency ratios could be used to measure how well Ingevity Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.25 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0). Change To Liabilities is likely to gain to about 51.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 219 M in 2024.
Ingevity Corp currently holds 1.53 B in liabilities with Debt to Equity (D/E) ratio of 1.88, which is about average as compared to similar companies. Ingevity Corp has a current ratio of 2.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Ingevity Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Matthias WolfgruberCabot
67
Allan SeligOil Dri
86
Paul HindsleyOil Dri
61
Frank WilsonCabot
62
Leslie GarberOil Dri
N/A
Juan EnriquezCabot
61
Michael MorrowCabot
65
John RodenH B Fuller
70
Michael NemeroffOil Dri
57
Douglas GrossoCabot
59
Paul SuckowOil Dri
73
Ruth KimmelshueH B Fuller
58
EllenBlair ChubeOil Dri
39
George RoethOil Dri
59
Thomas HandleyH B Fuller
66
Christine YanCabot
55
Daniel FlornessH B Fuller
57
Cynthia ArnoldCabot
62
Dante ParriniH B Fuller
56
William KirbyCabot
69
Maria HiladoH B Fuller
56
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina. Ingevity Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 1850 people. Ingevity Corp (NGVT) is traded on New York Stock Exchange in USA. It is located in 4920 O'Hear Avenue, North Charleston, SC, United States, 29405 and employs 1,700 people. Ingevity Corp is listed under Specialty Chemicals category by Fama And French industry classification.

Management Performance

Ingevity Corp Leadership Team

Elected by the shareholders, the Ingevity Corp's board of directors comprises two types of representatives: Ingevity Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingevity. The board's role is to monitor Ingevity Corp's management team and ensure that shareholders' interests are well served. Ingevity Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingevity Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
J Fitzpatrick, Independent Director
Stacy Cozad, Executive Vice President General Counsel, Company Secretary
Stuart Woodcock, Executive Materials
Daniel Sansone, Independent Director
John Nypaver, VP Relations
Christine Stunyo, Senior Officer
Jean Blackwell, Independent Chairman of the Board
Ryan Fisher, Vice President, Deputy General Counsel
Karen Narwold, Independent Director
Rich White, Senior Vice President - Performance Chemicals, and President Industrial Specialties and Pavement Technologies
Phillip Platt, Co Officer
John Fortson, President, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Director
Mary Hall, Chief Financial Officer, Executive Vice President, Treasurer
Caroline Monahan, Director Communications
Frederick Lynch, Lead Independent Director
Luis FernandezMoreno, Independent Director
Richard White, Senior Chemicals
Michael Smith, Executive Vice President and President Performance Chemicals, Strategy and Business Development
Diane Gulyas, Independent Director
Daniel Gallagher, VP Relations
Erik Ripple, VP Officer
Steven Hulme, Senior Technologies
S Woodcock, Executive Vice President and President - Performance Materials
Steve Hulme, Senior Vice President - Performance Chemicals, and President Engineered Polymers

Ingevity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ingevity Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Ingevity Stock Analysis

When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.